🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This study will evaluate the safety of adding nivolumab to several chemothe...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2016-06
Trial ID
NCT02764593
This phase II trial studies the side effects of chemotherapy and intensity ...
Status
Active Not Recruiting
Location
Zuckerberg San Francisco General Hospital
Start Date
2022-08-09
Trial ID
NCT04929028
Treatments Being Tested
This pilot phase I/II trial studies the side effects and how well nivolumab...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-01-07
Trial ID
NCT03776487
This phase II trial studies the side effects and best dose of ipilimumab, n...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-07-25
Trial ID
NCT03799445
This is a Phase 2, multicenter, open-label, 2-cohort (Locoregionally Advanc...
Status
Withdrawn
Location
University of California San Diego, UCSD
Start Date
2024-01-30
Trial ID
NCT05743270
Treatments Being Tested
This phase III trials studies whether maintenance immunotherapy (nivolumab)...
Status
Active Not Recruiting
Location
Thomas Hospital
Start Date
2019-08-16
Trial ID
NCT03811015
This phase II/III trial studies how well a reduced dose of radiation therap...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-10-09
Trial ID
NCT03952585
To date, the majority of clinical trials on checkpoint inhibitors have test...
Status
Completed
Location
Institut Curie
Start Date
2017-11-27
Trial ID
NCT03298893
Treatments Being Tested
This is a single-armed, multicenter, non-blinded phase 2 study to assess ef...
Status
Active Not Recruiting
Location
Antoni van Leeuwenhoek ziekenhuis
Start Date
2022-03-14
Trial ID
NCT05200988
Treatments Being Tested